Dark Daily Press Releases & News

Latest E-Briefings

Webinar: Meeting the Challenges of COVID-19 Testing: A User’s Experience with the Scalable, High Throughput Amplitude Solution

AUSTIN, Texas (July 23, 2021) – DARK Daily today announced an upcoming free webinar, “Meeting the Challenges of COVID-19 Testing: A User’s Experience Addressing the Unpredictable Testing Demand of Clinical Laboratories with the Scalable, High Throughput Amplitude Solution,” to be held Wednesday, July 28, 2021 at 1 pm EDT and available on-demand after that. Sponsored by Thermo Fisher, this webinar will discuss how one company’s rapid response to the COVID-19 testing needs of the global clinical laboratory community provided access to secured supply of consumables, workforce efficiencies, an automated high-throughput workflow, and committed service and support.

White Paper: Repurposing Your Lab’s Leftover COVID-19 Samples—Building New Revenue and Better Patient Outcomes through Collaboration with Life Sciences

AUSTIN, Texas (June 17, 2021) – DARK Daily today announced “Repurposing Your Lab’s Leftover COVID-19 Samples: Building New Revenue and Better Patient Outcomes through Collaboration with Life Sciences,” a free, 24-page white paper produced in collaboration with Ovation that explores how the rapid decline in SARS-CoV-2 testing affects molecular laboratories and the life sciences industry as a whole and offers opportunities for drug developers and labs to work together in new and beneficial ways.

Webinar: Best Practices for Launching Profitable, Efficient NGS Tests for Hereditary Risk

AUSTIN, Texas (June 16, 2021) – DARK Daily today announced “Best Practices for Launching Profitable, Efficient NGS Tests for Hereditary Risk,” a free webinar that will increase attendees’ understanding of NGS workflow considerations, data interpretation and analysis, and best practices for implementation. It will be held Wednesday, June 23, 2021 at 1 pm EDT and will be available on-demand after that. 

New Webinar: Clinical-Grade Artificial Intelligence (AI) for Your Pathology Lab

AUSTIN, Texas (June 14, 2021) – DARK Daily today announced the June 17, 2021 premium webinar, “Clinical-Grade Artificial Intelligence (AI) for Your Pathology Lab: What’s Ready Now, What’s Coming Soon, and How Pathologists Can Profit from Its Use.” This webinar will guide pathologists through the essentials of implementing AI in digital pathology and clinical practice—including how to fund their investment.

New Webinar: Identifying SARS-CoV-2 Mutations

AUSTIN, Texas (June 11, 2021) – DARK Daily today announced the June 16, 2021 free webinar, “Identifying SARS-CoV-2 Mutations: A Microarray Multiplex Alternative to Next Generation Sequencing or q-RT-PCR for Rapid COVID-19 Variant Identification.” This webinar brings clinical and public health labs and research institutions up to date on SARS-CoV-2 variant detection and the best options now available for identifying SARS-CoV-2 mutations.

New Webinar: How a Novel Molecular Screening Technology for Blood-Related Cancers Can Provide Operational and Cost-Effective Benefits to Your Lab

AUSTIN, Texas (June 3, 2021) – DARK Daily today announced the June 9, 2021 free webinar for molecular labs and pathology groups, “How a Novel Molecular Screening Technology for Blood-Related Cancers Can Provide Operational and Cost-Effective Benefits to Your Lab.” This webinar presents the benefits of Precipio’HemeScreen, a novel, proprietary technology that offers an alternative to the existing molecular testing modalities for blood-related cancers.

New Webinar on Adopting Digital Pathology on a Budget

AUSTIN, Texas (May 24, 2021) – DARK Daily today announced “Adopting Digital Pathology on a Budget: Getting Started, Knowing What’s Feasible, and Funding Your DP from Overlooked Sources.” This paid webinar investigates the different paths to digital pathology and how they can contribute towards new streams of revenue and increase pathologists’ compensation. Learn what’s new and different in digital pathology, whole slide imaging, and automated digital image analysis and how to bring digital pathology to your lab.

New Webinar on how to Maximize COVID-19 Test Claim Reimbursements and Prepare for Audits

AUSTIN, Texas (May 17, 2021) – DARK Daily today announced “Getting Paid for COVID-19 Test Claims: Prepare for Audits, Maximize Reimbursement, and Navigate New Payer Trends,” a 90-minute webinar that is taking place Wednesday, May 19 from 1-2:30 pm EDT and available to stream on-demand after. This webinar will help clinical laboratories avoid medical necessity denials and deal with payer disputes, optimize COVID-19 test billing claims and capture revenue; and understand what actions to take now to navigate the emerging payer trends.

New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.


New Webinar on Strategies for Laboratory Professionals to Drive Lab Stewardship

AUSTIN, Texas (May 5, 2021) – DARK Daily today announced “Strategies for Laboratory Professionals to Drive Lab Stewardship,” a new, free webinar sponsored by HC1 and Quest Diagnostics. “Strategies for Laboratory Professionals to Drive Lab Stewardship” explores the implementation of laboratory stewardship to increase effective test use, decrease costs, and improve patient care. Laboratory testing is typically the single highest-volume medical activity in a health system and plays a major role in driving clinical decision-making.

New Webinar on How Hospitals and Health Systems Can Prepare to Meet a New Blood Culture Contamination Benchmark

AUSTIN, Texas (May 5, 2021) Blood culture contamination is a significant issue that impacts all hospitals. Thirty-five to 50% of positive blood culture results indicating sepsis are false positives that resulted from touchpoint contamination and/or skin and skin plug contamination at the time of collection. These false-positive sepsis results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment.

New Report Helps Clinical Laboratories Level the Playing Field with Private Health Plans to Overcome Unpredictable Payer Policies and Get More COVID-19 Test Claims Paid in Full

AUSTIN, Texas (April 12, 2021) Since the outbreak of the SARS-CoV-2 pandemic last year, clinical laboratories submitting legitimate claims for COVID-19 tests regularly found themselves battling to get paid because certain private health plans simply denied these claims, often with no explanation for the denial. There are even cases where some private payers ignored federal and state laws requiring payment for COVID-19 test claims. But the end result is always the same: labs performed the COVID-19 test requested by the doctor, but the payer did not reimburse the claim.

DARK Daily: Webinar Shares How Lab Leaders Can Position Their Labs for Success in a Post-Pandemic World by Leveraging Their Diagnostic Data as a Strategic Asset


AUSTIN, Texas (March 31, 2021)
— With the SARS-CoV2 pandemic, labs across the globe were forced to rapidly adapt as the volume and breadth of testing dramatically shifted to support COVID-19 diagnostics. Labs experienced a 50-60% decline in the flow of routine specimens and revenues as higher value tests were paused or replaced with COVID-related diagnostics. But as COVID-19 testing volumes decrease, there’s no guarantee that higher-value tests will fill the void at the same rate.

New Webinar Featuring Experts from Sanford Consortium for Regenerative Medicine, Thermo Fisher Scientific, Andersen and Su Labs–Scripps Research, and Yeo Lab–UC San Diego Informs Lab Leaders on How to Identify Emerging SARS-CoV-2 Mutations

AUSTIN, Texas (March 30, 2021) — SARS-CoV-2 has been mutating at a rate of about one to two mutations per month. The emergence of multiple SARS-CoV-2 variants brings fast-moving questions for clinical laboratory administrators about the ability to identify new potential coronavirus SARS-CoV-2 variants. One of the most notable is how standard COVID-19 testing can be positioned to detect these new variants, particularly now that the S-gene dropout issue has been discovered.

Webinar helps labs better align coding, billing, and collection steps to generate more paid genetic test claims

AUSTIN, Texas (March 23, 2021) – Getting paid for genetic test claims continues to be the single biggest challenge for clinical labs and anatomic pathology groups. In response to the substantial surge in the numbers of new genetic tests, payers are placing tougher restrictions on how they accept and pay genetic test claims. Hear a panel of respected experts from Concert Genetics, XIFIN, and Bruce Quinn Associates, LLC discuss three approaches smart genetic testing executives can use to increase the number of genetic test claims that are reimbursed.

New Special Report provides legal, regulatory, and compliance guidelines for clinical laboratories working to develop profitable COVID-19 employee testing programs

AUSTIN, Texas (November 13, 2020) – There is an exploding market for COVID-19 employer testing programs, presenting tremendous opportunity for clinical laboratories. It is crucial for clinical laboratories to ensure that they have the  information they need in order to develop effective and profitable COVID-19 employee screening and testing programs.

New webinar featuring front-line speakers from the LA County Department of Public Health informs lab leaders on starting and scaling their COVID-19 testing

AUSTIN, Texas (July 30, 2020) – As the COVID-19 pandemic has swept across the world, medical laboratories of all types have been working around the clock to get testing up and running. Some labs, such as those which are hospital-based and academic medical center-affiliated, have fortunately had access to more resources and infrastructure as they scale up for testing volume. 

Recently published White Paper provides insights on the status of clinical utility of rapid molecular testing for UTI

AUSTIN, Texas (July 16, 2020) – Urinary tract infection (UTI) is the second most common type of infection in the US, accounting for 10.5 million office visits per year and 50 percent of all Medicare hospital admissions. UTI is among the most common cause of bacterial infections in long-term care facility residents.

Recently Published White Paper Helps Laboratory Professionals Understand Risks, Requirements, and Benefits of a Clinical Decision Support System

AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.

White Paper shows laboratory professionals how to equip clinical staff and administrators with skills needed to evaluate, measure and analyze in order to improve both lab operations and the bottom line

AUSTIN, Texas (June 30, 2020) – Now more than ever before, clinical labs are under pressure to operate efficiently, accurately, and promptly, all while still making money. Doctors and patients have come to expect a 24-hour turnaround for most tests. Clinical labs throughout the United States have been slashing budgets, many literally to the point of no return. At least 13 public health labs in four states have shuttered since 2003, which posed a serious problem when COVID-19 hit because resources did not meet demand.

Recently Published White Paper Provides Laboratory Professionals with Insights and Best Practices Addressing Quality Issues & Solutions Related to Medical Lab Specimen Management

AUSTIN, Texas (June 12, 2020) – The complexity of medical laboratory specimen sample management requires a highly sophisticated system of monitors, controls, and useful reports to meet lab and hospital accreditation requirements, prevent errors that can lead to costly quality failures, and reduce unnecessary healthcare costs.

New Webinar Demonstrates Streamlined Operations, Increased Revenue, and Higher Quality of Care as Conclusive Evidence on the Value of Adopting Digital Pathology in the Lab

AUSTIN, Texas (May 5, 2020) – Digital pathology has been positioned as a transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift; labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

Press Release: Is Anatomic Pathology at the Tipping Point? New White Paper Offers Economic Case for Adopting Digital Technology and AI Applications Now

AUSTIN, Texas (March 17, 2020) – As anatomic pathology laboratories struggle to remain profitable while they grapple with increasing workloads and sweeping reimbursement cuts, digital pathology and artificial intelligence (AI) applications have demonstrated their power to tackle these systemic challenges—enabling laboratories to overcome the unprecedented confluence of market pressures and to drive efficiency and quality gains.


Press Release: White Paper provides laboratory professionals with insights to effectively transform their lab into a strategic unit that drives clinical and financial value for itself and for the organization it serves

AUSTIN, Texas (February 7, 2020) – Powerful forces are reshaping the clinical laboratory industry, making 2020 a critical year as hospitals determine whether retaining the laboratory in-house or selling it is the better path. Mergers, acquisitions, and joint ventures, along with the development of new testing technologies are but a few of the factors that have changed the profile of the medical laboratory footprint across the U.S. And now, downward reimbursement reform combined with impending integration of clinical care, promise to again challenge the traditional laboratory service model in significant ways beyond 2020.


Press Release: The All-New Precision Medicine Institute Website Makes Its Debut

AUSTIN, Texas (December 23, 2019) — Entering its third year, Precision Medicine Institute has quickly gained a world-renowned reputation by differentiating itself from other precision medicine conferences. Rather than information delivered by clinicians speaking strictly about the practice of precision medicine and the science behind it, Precision Medicine Institute stands apart by delivering crucial management and operational intelligence from those who have already initiated (and learned from) their own precision medicine programs.


Press Release: White Paper provides laboratory professionals with practical insights & indispensable how-to’s regarding the myriad challenges associated with installing, converting, and interfacing a laboratory information system

AUSTIN, Texas (November 12, 2019) – A recent LIS market report shows that demand for a modern LIS is driven by a number of factors: acceleration of laboratory automation, the need for improved lab efficiency, advances in integrated functionality, importance of compliance with regulatory requirements, and the rising prevalence of chronic diseases. Indeed, because all laboratories are now routinely being asked to do more with less, these and numerous other urgent reasons are compelling independent and hospital laboratories to invest resources in a major laboratory information implementation or upgrade.


Press Release: Clinical Laboratory Innovators in Lean Six Sigma and Process Improvement to Gather in Atlanta October 15-16, 2019

AUSTIN, Texas (August 28, 2019) — In just over six weeks, the clinical lab industry’s leading experts in the use of Lean, Six Sigma, and other process improvement methods will gather for the annual Lab Quality Confab conference. This internationally-recognized event will take place October 15-16 at the Hyatt Regency, in the heart of downtown Atlanta, GA.


Press Release | DARK Daily: Smart Hospital and Health Network Laboratories Assessing Alternatives to Traditional Lab Practice Models in This Era of Declining Lab Reimbursement, Integrated Care Models, and Personalized Medicine

AUSTIN, Texas (August 27, 2019) The clinical laboratory industry is increasingly revolving around hospitals, health systems, and other integrated care delivery networks. Laboratories continue to be challenged with reimbursement reductions, value-based contracting demands, financial outcomes measured as total cost of care, not to mention a demand for complex and costly technologies.


 

Press Release | DARK Daily: How Proposed Medicare Physician Fee Schedule Changes May Impact Clinical Laboratory and Pathology Practices in 2020

AUSTIN, Texas (August 7, 2019) Proposed changes to the Medicare Physician Fee Schedule and Quality Payment Program means that clinical laboratories and pathology practices need to fully understand how their lab revenue can potentially be affected by these changes, and prepare accordingly.


Press Release | DARK Daily: Innovative Evidence-Based Technology Reduces Blood Culture Contamination, Improves Patient Care, and Reduces Costs in Clinical Labs and Hospitals

AUSTIN, Texas (July 18, 2019) – As a result of contamination of blood specimens at the time of collection, 35% to 50% of positive blood culture results indicating sepsis are actually false positive. These false positive results confound clinical decisions regarding antibiotic therapy, including selection and de-escalation of broad-spectrum antibiotic treatment. The result is that patients are often treated with unnecessary antibiotics, with attendant risks of secondary infection such as C. difficile, MDROs, and other antibiotic-associated complications.


Press Release: Improving Patient Outcomes Using the Principles of Lab 2.0 to Combat Opioid-Use Disorder

AUSTIN, Texas (June 11, 2019) Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.


Press Release: Compliance with New Federal EKRA Law Creates Uncertainties in How Clinical Laboratories Pay Commissions to Their Sales Teams

Austin, Texas (April 18, 2019) — EKRA (The Eliminating Kickbacks in Recovery Act) was passed October 24, 2018 as part of the SUPPORT Act, a combination of more than 70 bills aimed at fighting the current opioid epidemic. EKRA is intended to address patient brokering—in exchange for kickbacks—of individuals with substance abuse disorders.


Press Release: Hospitals May Face Federal Penalties of $10,000 Per Day If They Fail to Report PAMA Private Payer Clinical Laboratory Test Price Data to CMS in Early 2020

AUSTIN, Texas (April 1, 2019) — Recent surveys indicate that a majority of the nation’s hospital and health system CEOs and CFOs are unaware of the requirement that they report their private payer clinical laboratory test price data to the federal Centers for Medicare and Medicaid Services (CMS) starting Jan. 1, 2020. Hospitals that fail to report this data may be assessed penalties of up to $10,000 per day.


Press Release: DARK Daily | Revisions in PAMA private payer price data reporting requirements having a dramatic effect on laboratory organizations

(February 15, 2019) Recent changes made to PAMA regulations mean that many more hospital and other labs must now report their PAMA private payer price data to Medicare. These revisions are having a profound impact on hospital and other laboratories.


Webinar | Performance coaching a proven method to encourage the success of lab staff and ensure a sustainable Lean lab transformation

(January 11, 2019) Realities of the current healthcare environment are harsh: laboratories are constantly challenged to do more with less, and are faced with a shortage of skilled or experienced personnel.


Webinar: Clinical Laboratories Should Prepare Now to Make Their Labs Assessment-Ready in 2019

(December 12, 2018) PRESS RELEASE: Today’s tough healthcare environment means that laboratories face increasing pressure from all sides. Regulatory responsibilities can sometimes take a back burner to other pressing issues, causing some lab leaders to scramble in response to unexpected deficiencies identified by accreditors and CLIA inspectors.


White Paper: Creating a patient-centered lab with breakthrough blood collection technology: Using new microsampling methods provides reliable, economical collection, shipping and storage solutions

(October 11, 2018) – PRESS RELEASE: Patient-centered care, also known as the “patient-centric” approach, represents a paradigm shift in how patients and providers think about the processes of treatment. Patient-centric care can lead to a better patient experience—which in turn leads to improved adherence and compliance. Improved patient compliance is an essential contributing factor to the ultimate goal—enhanced treatment efficiency and safety, and better clinical outcomes. More technicians, and the clinicians who rely upon them, are adopting patient-centric technologies to improve the quality of patient care and thus support enhanced clinical outcomes. Included in this proliferation of new technologies are those based on concept of remote patient monitoring (RPM).


Preparing Health Network CEOs for Success with Precision Medicine: Early-Adopter Health Systems to Gather in Nashville September 12-13 to Share Advances in Oncology, Pharmacogenomics, Big Data

(August 14, 2018)—PRESS RELEASE: Precision Medicine is happening now at first-mover hospitals and health systems! September 12-13 in Nashville, experts from the nation’s most successful precision medicine clinical programs will gather to share their strategies and lessons learned. The goal of this conference is to provide hospital CEOs with the insights needed to initiate effective precision medicine programs in their own institutions.


Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians


The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


Healthcare’s Accelerating Transformation as Both Threat and Potential for Anatomic Pathologists: Useful Steps to Help Labs with Eroding Practice Finances and Unwelcome Payer Trends, Plus New Clinical Opportunities

AUSTIN, Texas (March 30, 2018)—As new technology is incorporated into the practice of pathology, as consolidations increase, as reimbursement models evolve, and as consumerism takes on a more important role in healthcare—the field of pathology continues to transform.


PRESS RELEASE: Labs get updated on the latest issues catching them off-guard during accreditation assessments and surprise visits from CLIA inspectors, by learning from the top accreditation organizations in a non-inspection setting

New Webinar to Focus on ‘Private Practice Pathology,’ Explain Current Realities and Forthcoming Opportunities

AUSTIN, Texas (February 19, 2018) – Pathology Webinars, LLC, a leading pathology and medical laboratories educational authority, will host a brand new informative webinar, “Private Practice Pathology – Today’s Reality and Tomorrow’s Opportunities with More Access to Managed Care Contracts, Regional Pathology Consolidation, Pathologist Productivity and Compensation, and Getting Paid for Claims,” on Wednesday, February 28, 2018, at 2:00 p.m. EST.


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 


Fines, decreased reimbursements, and more frequent payer audits await those clinical labs and pathology groups not prepared for tougher legal and regulatory changes starting January 1, 2018

AUSTIN, Texas (November 2, 2017)—The list of regulatory, compliance and managed care threats that must be addressed by clinical labs and pathology group practices in 2018 is lengthy. Each comes with the potential of government sanctions, exclusion from provider networks, large recoupment demands, and greater risk for individual liability of lab directors and lab managers that can include jail time, sizeable fines, and exclusion from federal health programs.


What Does FDA Approval of a Digital Pathology System for Use in Primary Diagnosis Mean for the Pathology Industry? New Dark Daily Webinar to Provide Answers and Insights for Pathologists and Pathology Practice Administrators

AUSTIN, Texas (July 28, 2017)—Experts agree that the FDA’s long-awaited clearance earlier this year of a Digital Pathology system for use in primary diagnosis is the trigger event for a wave of clinical, operational, financial, and professional transformation. This decision has confronted every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to their group practice or medical laboratory?


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

AUSTIN, Texas (May 23, 2017): Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different manner.


New and powerful trend in the laboratory industry contributes to increased lab revenue and supports clinicians for better clinical outcomes

AUSTIN, Texas (April 5, 2017) It is now possible for medical laboratories to increase their revenues specifically because their labs are helping physicians achieve better patient outcomes. This is welcome news, particularly if a lab is seeking ways to offset price cuts and shrinking budgets.


Ongoing change in the healthcare industry has resulted in an overwhelming need for clinical laboratories and pathology groups to do more with less, while finding new ways to grow

AUSTIN, Texas (March 8, 2017) – The year 2016 was one of continuing change for the healthcare industry. The result has been more pressure than ever in 2017 to meet the demands of informed consumers while balancing new regulations. For clinical laboratories and anatomic pathology groups, these myriad changes have also resulted in a pressing need to achieve more with fewer resources, and at the same time finding ways to grow.


Ever more physicians are including elements of precision medicine in their practice, making it imperative that every clinical laboratory and pathology group have a strategy for how it will serve precision medicine

AUSTIN, Texas (March 7, 2017) Tests in support of precision medicine will be the fastest-growing sector of laboratory medicine for years to come. Physician demand for these tests is robust and will continue to increase for a powerful reason: patients want the benefits from a test that delivers a more accurate diagnosis while pointing the doctor to the right therapy that will benefit the patient while minimizing side effects.


Medical Laboratories and Pathology Groups face greater risks when cutting costs to balance budgets; one solution is to identify and correct recurring sources of bad quality in clinical lab testing

AUSTIN, Texas (February 16, 2017) Cost-cutting is a priority activity at every clinical laboratory and anatomic pathology practice across the United States, as hospitals continue to decrease lab budgets and payers relentlessly pay less money for lab tests.

 

;